294 related articles for article (PubMed ID: 38615304)
1. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
Apoptosis; 2024 Apr; ():. PubMed ID: 38615304
[TBL] [Abstract][Full Text] [Related]
2. The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review.
Liu M; Kong XY; Yao Y; Wang XA; Yang W; Wu H; Li S; Ding JW; Yang J
Ann Transl Med; 2022 Mar; 10(6):368. PubMed ID: 35434035
[TBL] [Abstract][Full Text] [Related]
3. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
4. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
6. Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis.
Wang X; Kong X; Feng X; Jiang DS
Int J Biol Sci; 2023; 19(11):3558-3575. PubMed ID: 37497000
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases.
Lv Y; Wu M; Wang Z; Wang J
Cell Biol Toxicol; 2023 Jun; 39(3):827-851. PubMed ID: 36459356
[TBL] [Abstract][Full Text] [Related]
9. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Induces Ferroptosis in A549 CD133
Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma.
Liu MR; Shi C; Song QY; Kang MJ; Jiang X; Liu H; Pei DS
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37695069
[TBL] [Abstract][Full Text] [Related]
13. FSP1: a key regulator of ferroptosis.
Li W; Liang L; Liu S; Yi H; Zhou Y
Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
[TBL] [Abstract][Full Text] [Related]
14. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
15. Involvement of FSP1-CoQ
Yang M; Tsui MG; Tsang JKW; Goit RK; Yao KM; So KF; Lam WC; Lo ACY
Cell Death Dis; 2022 May; 13(5):468. PubMed ID: 35585057
[TBL] [Abstract][Full Text] [Related]
16. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance.
Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J
Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Rewiring toward Oxidative Phosphorylation Disrupts Intrinsic Resistance to Ferroptosis of the Colon Adenocarcinoma Cells.
Gotorbe C; Durivault J; Meira W; Cassim S; Ždralević M; Pouysségur J; Vučetić M
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552620
[TBL] [Abstract][Full Text] [Related]
19. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
20. Endogenous chemicals guard health through inhibiting ferroptotic cell death.
Song YH; Lei HX; Yu D; Zhu H; Hao MZ; Cui RH; Meng XS; Sheng XH; Zhang L
Biofactors; 2024; 50(2):266-293. PubMed ID: 38059412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
